Renuse, S.; Madamsetty, V.S.; Mun, D.-G.; Madugundu, A.K.; Singh, S.; Udainiya, S.; Mangalaparthi, K.K.; Kim, M.-S.; Liu, R.; Kumar, S.R.;
et al. Tyrosine Phosphoproteomics of Patient-Derived Xenografts Reveals Ephrin Type-B Receptor 4 Tyrosine Kinase as a Therapeutic Target in Pancreatic Cancer. Cancers 2021, 13, 3404.
https://doi.org/10.3390/cancers13143404
AMA Style
Renuse S, Madamsetty VS, Mun D-G, Madugundu AK, Singh S, Udainiya S, Mangalaparthi KK, Kim M-S, Liu R, Kumar SR,
et al. Tyrosine Phosphoproteomics of Patient-Derived Xenografts Reveals Ephrin Type-B Receptor 4 Tyrosine Kinase as a Therapeutic Target in Pancreatic Cancer. Cancers. 2021; 13(14):3404.
https://doi.org/10.3390/cancers13143404
Chicago/Turabian Style
Renuse, Santosh, Vijay S. Madamsetty, Dong-Gi Mun, Anil K. Madugundu, Smrita Singh, Savita Udainiya, Kiran K. Mangalaparthi, Min-Sik Kim, Ren Liu, S. Ram Kumar,
and et al. 2021. "Tyrosine Phosphoproteomics of Patient-Derived Xenografts Reveals Ephrin Type-B Receptor 4 Tyrosine Kinase as a Therapeutic Target in Pancreatic Cancer" Cancers 13, no. 14: 3404.
https://doi.org/10.3390/cancers13143404
APA Style
Renuse, S., Madamsetty, V. S., Mun, D.-G., Madugundu, A. K., Singh, S., Udainiya, S., Mangalaparthi, K. K., Kim, M.-S., Liu, R., Kumar, S. R., Krasnoperov, V., Truty, M., Graham, R. P., Gill, P. S., Mukhopadhyay, D., & Pandey, A.
(2021). Tyrosine Phosphoproteomics of Patient-Derived Xenografts Reveals Ephrin Type-B Receptor 4 Tyrosine Kinase as a Therapeutic Target in Pancreatic Cancer. Cancers, 13(14), 3404.
https://doi.org/10.3390/cancers13143404
